Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results.
The TRUST (EvaluaTion of Bladder Function in Relapsing-Remitting MUltiple Sclerosis Patients Treated with Natalizumab) Observational Study.
Antiinflammatory activity of glucomoringin isothiocyanate in a mouse model of experimental autoimmune encephalomyelitis.
Multiple Sclerosis: Risk Factors and Their Interactions.
The use of Doppler ultrasound in the diagnosis of chronic cerebrospinal venous insufficiency.
'Hidden' factors influencing quality of life in patients with multiple sclerosis.
Grey matter lesions in MS: From histology to clinical implications.
Prenatal vitamin d deficiency induces an early and more severe experimental autoimmune encephalomyelitis in the second generation.
Systemic treatment with the inhibitory neurotransmitter gamma-aminobutyric acid aggravates experimental autoimmune encephalomyelitis by affecting proinflammatory immune responses.
Measurement and treatment of imbalance and fall risk in multiple sclerosis using the international classification of functioning, disability and health model.
A standardized motor imagery introduction program (MIIP) for neuro-rehabilitation: development and evaluation.
Hippocampal volume is related to cognitive decline and fornicial diffusion measures in multiple sclerosis.
Quantitative texture analysis of brain white matter lesions derived from T2-weighted MR images in MS patients with clinically isolated syndrome.
Neuropathic Pain in Multiple Sclerosis Improved With Oral Famciclovir: A Case Report.
Does HLA Class II Haplotype play a role in Adult Acute Disseminated Encephalomyelitis? Preliminary Findings from a Southern Italy hospital-based study.
Diagnostic utility of NMO/AQP4-IgG in evaluating CNS inflammatory disease in Thai patients.
Acute combined central and peripheral demyelination showing anti-aquaporin 4 antibody positivity.
Changes in tissue directionality reflect differences in myelin content after demyelination in mice spinal cords.
Small and Long Regulatory RNAs in the Immune System and Immune Diseases.
A salty taste to autoimmunity.
Spasticity in patients with multiple sclerosis - clinical characteristics, treatment and quality of life.
A comparative analysis of Patient-Reported Expanded Disability Status Scale tools.
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis.
High spatial and angular resolution diffusion-weighted imaging reveals forniceal damage related to memory impairment.
Isolation & characterization of Bartonella sp. from optic neuritis patients.
Pages
« first
‹ previous
…
305
306
307
308
309
310
311
312
313
…
next ›
last »